Sponsored session: A turning point in JIA treatment for the appropriate patient: Exploring tofacitinib’s role
Tracks
Rotterdam 1
| Friday, September 29, 2023 |
| 15:15 - 16:15 |
| Rotterdam Hall 1 |
Speaker
Alberto Martini
UNIVERSITY OF GENOA
Welcome and faculty introductions
15:15 - 15:20Biography
Ivan Foeldvari
HAMBURGER ZENTRUM FÜR KINDER- UND JUGENDRHEUMATOLOGIE
The current JIA treatment paradigm and unmet needs
15:20 - 15:30Biography
Joost Swart
UMC UTRECHT
Tofacitinib as a treatment option for patients with pJIA
15:30 - 15:40Biography
Joost Swart
UMC UTRECHT
Patient preference is key to both patients and HCPs prescribing tofacitinib
15:40 - 15:47Biography
Ivan Foeldvari
HAMBURGER ZENTRUM FÜR KINDER- UND JUGENDRHEUMATOLOGIE
The role of transitional care in JIA patients
15:47 - 15:55Biography
All
Faculty Q&A and discussion
15:55 - 16:10Biography
Alberto Martini
UNIVERSITY OF GENOA
Summary and close
16:10 - 16:15Biography
